- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05772221
The Role of Social Determinants in Cardiovascular Health and Vascular Function (CVRRC)
July 25, 2023 updated by: Baylor Research Institute
The Role of Social Determinants in Cardiovascular Health and Vascular Function in a Racial and Ethnic Minority Population at High Risk for Disparities
This study aims to identify the influence of social determinants of health domains on vascular function in a low income, racial, and ethnic minority population at risk for disparities.
We hypothesize that individuals of a lower social economic position and those struggling with depression are at greater risk of cardiovascular disease.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
This study aims to identify the influence of social determinants of health domains on vascular function in a low income, racial, and ethnic minority population at risk for disparities.
We hypothesize that individuals of a lower social economic position are at greater risk of impairment in the large organ that is responsible for blood movement in the body and artery stiffness.
Additional sims include identifying the influence of depression on vascular function and measure the interaction between depression and social determinants of health.
We hypothesize that impairment will be greater in individuals with depression than in individuals without.
Finally we will compare a comprehensive metabolic project against the social determinants of health and depression, hypothesizing that more severe social determinants of health and depression will increase the risk of cardiovascular disease.
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Brittany Meredith, MSW
- Phone Number: 214-865-2422
- Email: brittany.meredith@bswhealth.org
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75210
- Recruiting
- Baylor Scott & White Family Health Center at Juanita J. Craft Recreation Center
-
Contact:
- Patricia Allison
- Email: patricia.allison@bswhealth.org
-
Contact:
- Libertad Gracia
- Email: libertad.gracia@bswhealth.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age 18 or older and ability to read.
Exclusion Criteria:
- (1) unable to provide informed consent (e.g., due to acute impairment or psychosis), (2) inability to read, (3) previously enrolled in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Interviewer-Administered
Screening assessments to measure social determinants of health in relation to cardiovascular disease.
|
Screening assessments to measure social determinants of health in relation to cardiovascular disease.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Health Questionnaire (PHQ-9)
Time Frame: 1 year
|
The PHQ-9 is a self-report measure that assesses the frequency of symptoms on each of the nine DSM-IV criteria for depression for "the last two weeks.".
Total scores of 5-9 represent mild depression, 10-14 represent moderate depression, 15-19 represent moderately severe depression, and > 20 represent severe depression.
|
1 year
|
Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: 1 year
|
The GAD-7 is a seven-item self-report scale for identifying the presence of generalized anxiety disorder (GAD) and assessing symptom severity.
The items of the GAD- 7 are based on the diagnostic criteria for GAD in the DSM-IV and assess frequency of symptoms over the last two weeks.
A score of 10 or greater on the GAD-7 represents a point for identifying cases of GAD.
Cut points of 5, 10, and 15 represent mild, moderate, and severe levels of anxiety, respectively.
|
1 year
|
PTSD Checklist for DSM-V (PCL-5)
Time Frame: 1 year
|
The PCL-5 is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of PTSD.
A total symptom severity score (range - 0-80) can be obtained by summing the scores for each of the 20 items.
Initial research suggests that a PCL-5 cutoff score between 31-33 is indicative of probable PTSD across samples.
|
1 year
|
Perceived Stress Scale
Time Frame: 1 Year
|
The Perceived Stress Scale is a 10-item questionnaire widely used to assess stress levels in young people and adults aged 12 and above.
It evaluates the degree to which an individual has perceived life as unpredictable, uncontrollable, and overloading over the previous month.
Higher scores indicate higher levels of perceived stress.
|
1 Year
|
AAFP Social Needs Screening Tool
Time Frame: 1 year
|
This tool is a 15-item questionnaire about a participant's social needs.
Social need categories measured by this instrument include housing, food, childcare, employment, education, finances, personal safety, and assistance.
Scoring of this instrument highlights areas in an individual's life where there may be a social need.
|
1 year
|
MacArthur Scale of Subjective Social Status
Time Frame: 1 year
|
The MacArthur Scale of Subjective Social Status (MacArthur SSS Scale) is a two-item measure that assesses a person's perceived rank relative to others in their group.
Respondents view a drawing of a ladder with 10 rungs, and either read or hear that the ladder represents where people stand in society.
|
1 year
|
Quality of Life (WHOQOL-BREF)
Time Frame: 1 year
|
The WHOQOL-BREF is a 26-item quality of life assessment.
It looks at the domains of physical health, psychological, social relationships, and environment.
The four domain scores denote an individual's perception of quality of life in each particular domain.
|
1 year
|
Experiences of Discrimination (EOD)
Time Frame: 1 year
|
The EOD is a short self-report instrument.
It looks at individuals self-reported experiences of discrimination.
Experiences of discrimination categories measures by this instrument include worry questions, global questions, filed complaints, major discrimination, day-to-day unfair treatment, and response to unfair treatment.
|
1 year
|
WHODAS 2.0 (World Health Organization Disability Assessment Schedule)
Time Frame: 1 year
|
The WHODAS is a 36-item version, self- administered assessment.
This measure assesses disability across dix domains, including understanding and communicating, getting around, self-care, getting along with people, lie activities, and participation in society.
|
1 year
|
Social Isolation
Time Frame: 1 year
|
Is a 3-item scale used to assess feelings of loneliness or social isolation.
Each item has a minimum score of 1 and a maximum score of 3. The higher scores indicate a greater degree of loneliness.
|
1 year
|
Adverse Childhood Experiences (ACE)
Time Frame: 1 year
|
ACE is a 10-item measure used to measure childhood trauma.
This questionnaire assesses 10 types of trauma, 5 being personal, physical abuse, verbal abuse, sexual abuse, physical neglect, and emotional neglect and 5 related to family members.
|
1 year
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: 1 year
|
PSQI is a self-rated questionnaire which assesses sleep quality and disturbances over a one-month period.
This measure assesses the following subcategories, sleep quality, latency, duration, habitual sleep efficiency, disturbances use of sleep medication, and daytime dysfunction.
|
1 year
|
International Physical Activity Questionnaire (IPAQ)
Time Frame: 1 year
|
The IPAQ is a 27-item long form, assessing physical activity over the last 7 days.
This measure looks at job-related physical activity, transportation physical activity, housework, house maintenance, and caring for family, recreation, sport, and leisure-time physical activity, and time spent sitting.
|
1 year
|
Connor-Davidson Resilience Scale (CD-RISC-10)
Time Frame: 1 year
|
CD-RISC-10 is a 10-item self-report scale measuring resilience.
This scale measures resilience and how well an individual is equipped to bounce back after stressful events, tragedy, or trauma.
Each item has a minimum score of 0 and a maximum score of 4. Total scores range from 0 to 40.
A higher score indicates higher resilience.
|
1 year
|
Tobacco, Alcohol, Prescription drug, and illicit Substance use Electronic Spanish Platform (TAPS-ESP)
Time Frame: 1 year
|
TAPS is a two-stage screening and brief assessment tool that first screens the four broad substance abuse categories (tobacco, alcohol, prescription drug misuse, and illicit substances), then branches to the brief assessment in which the individual is assessed for more specific risks related to an expanded array of substances (tobacco, alcohol, cannabis, cocaine, methamphetamines, prescription stimulants, heroin, prescription opioids, sedatives, and other substances).
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Katherine Sanchez, PhD, Baylor Scott and White Research Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 29, 2023
Primary Completion (Estimated)
December 31, 2023
Study Completion (Estimated)
December 31, 2023
Study Registration Dates
First Submitted
March 2, 2023
First Submitted That Met QC Criteria
March 15, 2023
First Posted (Actual)
March 16, 2023
Study Record Updates
Last Update Posted (Actual)
July 27, 2023
Last Update Submitted That Met QC Criteria
July 25, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 022-215
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Time Frame
One year
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
Clinical Trials on Screening
-
Vastra Gotaland RegionRecruiting
-
University of FloridaPatient-Centered Outcomes Research InstituteEnrolling by invitation
-
Peking University People's HospitalSun Yat-sen University; Fudan University; Sun Yat-Sen Memorial Hospital of Sun... and other collaboratorsCompletedBreast Cancer | Bone MetastasesChina
-
National Institute of Allergy and Infectious Diseases...Ohio Department of Health, City of Cincinnati Board of HealthCompleted
-
University of La LagunaCompletedHepatitis C Virus InfectionSpain
-
University of British ColumbiaUniversity of SydneyRecruitingCardiovascular Diseases | End Stage Renal Disease | Kidney Transplantation | Dialysis Related ComplicationCanada, United States, United Kingdom, Germany
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
LMC Diabetes & Endocrinology Ltd.RecruitingType 2 Diabetes | Nonalcoholic SteatohepatitisCanada
-
University of PittsburghNational Institute of Mental Health (NIMH); Kaiser Foundation Research InstituteCompleted
-
University of La LagunaRecruiting